Hilary Black as its Chief Advocacy Officer, effective immediately. In her expanded role, Hilary's mandate includes driving patient advocacy efforts worldwide, executing the Company's global corporate social responsibility strategy, and leading the implementation of best practices for diversity & inclusion.
"My unconventional path to the executive level speaks to Canopy Growth's respect for the trailblazers that for many decades fought for legal cannabis access," said Hilary Black, Chief Advocacy Officer, Canopy Growth. "For my entire adult life, I have broken down barriers so that patients could access cannabis. Being with Canopy Growth has exponentially amplified these efforts. I feel a tremendous sense of responsibility and privilege to build on this legacy of compassion and carry out a mandate that will improve the lives of patients around the world."
"As Chief Advocacy Officer, Hilary will further advance our mission to positively impact the wellbeing of neighbours, customers, and communities globally," commented Mark Zekulin, President & Co-CEO, Canopy Growth. "Today's announcement marks a significant step forward in our efforts to scale our corporate social responsibility initiatives and advocacy efforts on a global level."
Prior to being appointed Chief Advocacy Officer, Hilary served as Director of Patient Education & Advocacy. During that time she spearheaded several initiatives, including:
A $2.5 million donation to the University of British Columbia to establish the Canopy Growth Professorship of Cannabis Science, held by Dr. M-J Milloy, who is examining the potential utility of cannabis in addressing the opioid crisis.
Securing and facilitating patient consultations for the federal government's Task Force on Cannabis Legalization and Regulation, and with Health Canada.
A partnership with Parent Action on Drugs and Canadian Students for Sensible Drug Policy to develop evidence-based resources which parents and other adults can use to have informed conversations with youth about healthy and responsible cannabis use.
A three-way partnership with the Canadian Drug Policy Coalition (CDPC) and Mothers Against Drunk Driving Canada (MADD Canada) which saw CDPC conduct an extensive research review and education strategy, which informed MADD Canada's impaired driving campaign. This campaign is aimed at increasing awareness and education surrounding the dangers of driving under the influence of cannabis.
Previous to her career at Canopy Growth, Hilary founded the British Columbia Compassion Club Society (BCCCS), the first medical cannabis dispensary in Canada. She has been dedicated to serving patients for more than 20 years and continues to be committed to breaking down barriers to accessing medical cannabis for all patients. Hilary is also a recipient of the Queen Elizabeth Diamond Jubilee Award, an award that acknowledges her significant contribution to Canadian society for her work with medical cannabis.